NCI Diversity Supplements were awarded to Val (Rapid detection of CRLF2 rearrangements in Hispanic Ph-like ALL patients to access diagnosis and relapse) and Mel (Effect of dietary, pharmacological, and genetic topoisomerase ablation on Ph-like ALL risk in Hispanics) to fully fund their research projects for 3 years! 🤩
Val and Mel Awarded NCI Diversity Supplements!
on